Standout Papers

Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients wit... 2014 2026 2018 2022 763
  1. Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema (2014)
    David S. Boyer, Young Hee Yoon et al. Ophthalmology

Immediate Impact

55 standout
Sub-graph 1 of 17

Citing Papers

Customizable virus-like particles deliver CRISPR–Cas9 ribonucleoprotein for effective ocular neovascular and Huntington’s disease gene therapy
2025 Standout
Age-Related Macular Degeneration
2024 Standout
4 intermediate papers

Works of Yehia Hashad being referenced

A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema
2016
Outcomes following three-line vision loss during treatment of neovascular age-related macular degeneration: subgroup analyses from MARINA and ANCHOR
2011
and 1 more

Author Peers

Author Last Decade Papers Cites
Yehia Hashad 1566 1108 132 15 1.6k
Chirag Jhaveri 1102 929 193 19 1.2k
Abdhish R. Bhavsar 1126 758 112 29 1.3k
Paul M. Beer 1252 619 117 27 1.3k
J. García Sánchez 1132 934 150 42 1.3k
Allison R. Ayala 1447 1316 212 24 1.6k
Troels Vinding 1132 794 224 29 1.4k
Satyanarayana S Vedula 1046 833 168 19 1.4k
Frances Kane 1092 792 146 14 1.2k
R J Antcliff 1165 625 240 17 1.3k
Carl W. Baker 1382 1198 154 24 1.5k

All Works

Loading papers...

Rankless by CCL
2026